ETC
Exchange Traded Concepts’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $903K | Buy |
+18,555
| New | +$903K | 0.01% | 706 |
|
|
2025
Q1 | – | Sell |
-16,127
| Closed | -$635K | – | 1287 |
|
|
2024
Q4 | $635K | Sell |
16,127
-3,065
| -16% | -$121K | 0.01% | 743 |
|
|
2024
Q3 | $902K | Buy |
19,192
+3,563
| +23% | +$167K | 0.02% | 552 |
|
|
2024
Q2 | $844K | Buy |
15,629
+3,650
| +30% | +$197K | 0.02% | 495 |
|
|
2024
Q1 | $816K | Buy |
+11,979
| New | +$816K | 0.02% | 487 |
|
|
2023
Q2 | – | Sell |
-22,185
| Closed | -$1M | – | 1325 |
|
|
2023
Q1 | $1M | Buy |
+22,185
| New | +$1M | 0.03% | 329 |
|
|
2021
Q2 | – | Sell |
-342
| Closed | -$42K | – | 1130 |
|
|
2021
Q1 | $42K | Buy |
342
+39
| +13% | +$4.79K | ﹤0.01% | 825 |
|
|
2020
Q4 | $46K | Sell |
303
-5,285
| -95% | -$802K | ﹤0.01% | 746 |
|
|
2020
Q3 | $467K | Buy |
5,588
+1,477
| +36% | +$123K | 0.03% | 317 |
|
|
2020
Q2 | $302K | Buy |
4,111
+1,963
| +91% | +$144K | 0.05% | 372 |
|
|
2020
Q1 | $91K | Buy |
2,148
+1,254
| +140% | +$53.1K | 0.05% | 266 |
|
|
2019
Q4 | $54K | Buy |
+894
| New | +$54K | 0.01% | 274 |
|